Related Experiment Video
Updated: Jun 12, 2025

06:53
Use of Dual Optical Tweezers and Microfluidics for Single-Molecule Studies
Published on: November 18, 2022
2.1K
In-vitro blood purification using tiny pinch holographic optical tweezers based on deep learning
Xiao Luo1, Yu Ching Wong1, Xiangyu Chen2
1Department of Physics, The Hong Kong University of Science and Technology, China.
Biosensors & Bioelectronics
|September 18, 2024
Summary
Researchers developed a programmable, non-contact blood purification system for precise on-demand filtering. This advanced technology accurately detects and extracts blood components with high efficiency, paving the way for new medical treatments.
Area of Science:
- Biomedical Engineering
- Medical Devices
- Cell Biology
Background:
- In-vitro blood purification is critical for medical treatments, necessitating precise component separation.
- Current methods for blood component extraction lack a general, on-demand approach.
- Efficient and accurate blood filtering remains a significant challenge in medical applications.
Purpose of the Study:
- To introduce the first programmable non-contact blood purification system.
- To enable accurate detection and extraction of diverse blood components.
- To overcome limitations of existing blood purification techniques.
Main Methods:
- Development of a novel blood component object detection dataset and deep learning models.
- Fabrication of a microfluidic chip for controlled fluid handling.
- Implementation of a customized holographic optical tweezer for non-contact cell manipulation.
Main Results:
- Real-time blood fractionation with high precision (up to 96.89%) achieved.
- Demonstrated high efficiency in detecting and extracting target blood components.
- Validated the system's capability for accurate cell and particle identification.
Conclusions:
- The developed system offers a programmable, non-contact solution for blood purification.
- High precision and efficiency in blood component separation were empirically demonstrated.
- The system's scalability and flexibility present new avenues for blood treatment research.

